Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients with Brain Lesions.

Abroad (travel likely)Recruiting

Conditions

Glioblastoma · Glioma · Astrocytoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

HUB-Erasme Hospital, Brussels, Belgium
Contact: Study coordinator (Thibault Vanbutsele) · thibault.vanbutsele@hubruxelles.be · 25558167

Study leads

Xavier De Tiège, MD,PhD
Study Chair
Laboratoire de Neuroanatomie et Neuroimagerie translationnelles Université Libre de Bruxelles

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

Astrocytoma · Glioma · Recurrent Glioblastoma

Abroad (travel likely)RecruitingPHASE1

Bethesda, United States

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

Glioblastoma · Anaplastic Astrocytoma · Anaplastic Oligoastrocytoma

Abroad (travel likely)RecruitingPHASE2

New York, United States

Implantable Microdevice In Primary Brain Tumors

Grade II Glioma · Grade III Glioma · Grade IV Glioma

Abroad (travel likely)RecruitingEARLY_PHASE1

Boston, United States

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype · Astrocytoma, Grade III

Abroad (travel likely)RecruitingPHASE1, PHASE2

Chicago, United States · New York, United States